Kinaxis (TSE:KXS - Get Free Report) had its price objective increased by investment analysts at Royal Bank Of Canada from C$225.00 to C$235.00 in a report issued on Friday,BayStreet.CA reports. Royal Bank Of Canada's target price would indicate a potential upside of 18.82% from the stock's previous close.
Several other research firms have also recently issued reports on KXS. ATB Capital cut Kinaxis from an "outperform" rating to a "sector perform" rating and set a C$210.00 price objective on the stock. in a report on Friday, May 9th. Atb Cap Markets cut Kinaxis from a "strong-buy" rating to a "hold" rating in a report on Thursday, May 8th. BMO Capital Markets lifted their price objective on Kinaxis from C$190.00 to C$225.00 in a report on Friday, May 9th. Finally, Stifel Nicolaus raised their target price on shares of Kinaxis from C$225.00 to C$245.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of C$216.43.
Get Our Latest Stock Report on Kinaxis
Kinaxis Price Performance
KXS stock traded up C$1.62 during trading on Friday, hitting C$197.77. The stock had a trading volume of 15,437 shares, compared to its average volume of 76,318. The company has a debt-to-equity ratio of 12.12, a current ratio of 1.89 and a quick ratio of 2.29. Kinaxis has a twelve month low of C$132.93 and a twelve month high of C$212.45. The stock has a market capitalization of C$3.98 billion, a P/E ratio of 196.29, a PEG ratio of 3.60 and a beta of 0.78. The company's 50-day moving average price is C$200.84 and its two-hundred day moving average price is C$182.25.
Insider Buying and Selling at Kinaxis
In other news, Senior Officer Michael David Mauger sold 1,310 shares of Kinaxis stock in a transaction that occurred on Monday, June 23rd. The shares were sold at an average price of C$198.66, for a total transaction of C$260,242.24. Also, Senior Officer Vasile Gelu Ticala sold 3,534 shares of Kinaxis stock in a transaction that occurred on Friday, June 13th. The shares were sold at an average price of C$201.00, for a total transaction of C$710,334.00. Following the sale, the insider directly owned 596 shares in the company, valued at approximately C$119,796. The trade was a 85.57% decrease in their position. Over the last 90 days, insiders sold 15,510 shares of company stock valued at $3,077,806. Company insiders own 1.20% of the company's stock.
Kinaxis Company Profile
(
Get Free Report)
Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation.
See Also

Before you consider Kinaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.
While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.